Actualités de SWITZERLAND
- 2plus
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand
Cham, Switzerland (ots/PRNewswire) - Meridian Energy will deploy the OCEAN Charge Point Management System for the management and monetization of their public charging network across the country. Etrel, a Landis+Gyr (SIX: LAND) company providing integrated e-mobility solutions, and Meridian Energy, New Zealand's largest electricity generator, signed an agreement to ...
plus- 2
LKQ Europe is Committed to Becoming a Net-Zero Emissions Company
plus - 15
LKQ Expects Major Savings in Cost and CO2 from Traction Battery Repair and Remanufacturing
plus Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance
Zug, Switzerland (ots/PRNewswire) - In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen while preserving a healthy microbiome Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of XZ.700, a novel antibacterial enzyme, in ...
plusDEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES
plus- 2
FDI World Dental Federation launches Consensus Statement on Sustainable Oral Healthcare / Paving the way for an industry Code of Good Practice
plus Proman partners with CropX to invest in cutting-edge technology to make farming more sustainable
Wollerau, Switzerland (ots/PRNewswire) - Proman, an integrated energy company and one of the world's top ten nitrogen fertilizer producers, today announced a new strategic partnership with CropX, a global pioneer in digital farm management systems. CropX technology provides farmers and industry experts with the data and information they need to increase farming ...
plusMoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody® Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa with HiSCR75 as the primary endpoint
Zug, Switzerland (ots/PRNewswire) - - This Phase 2 study represents an important step in hidradenitis suppurativa ("HS") clinical development, as it will be the first to use the higher clinical response level of HiSCR75 as the primary endpoint - Expected to enroll over 200 patients with moderate-to-severe HS to ...
plusENG - Temera, Luxochain & Polygon, announce the collaboration with Bulgari for the launch of the new Octo Finissimo Ultra
Lugano, Switzerland (ots/PRNewswire) - Temera, Luxochain and Polygon are pleased to announce their role as partners for the launch project of the new model Octo Finissimo Ultra, available in a limited edition of only 10 pieces. Bulgari with this initiative masters again its leadership as innovator in the hard luxury ...
plusCompass Financial Technologies
COMPASS LAUNCHES FUNDAMENTAL DEFI INDEX AS INSTITUTIONAL DEMAND IN DIGITAL ASSETS CONTINUES TO SOAR
Lausanne, Switzerland (ots/PRNewswire) - Compass Financial Technologies, a leading crypto index provider that calculates indices that track over $5bn in assets announces the launch of the Compass Crypto Basket Fundamental DeFi Index (CCBFDEFI) - providing a reliable institutional benchmark to one of the fastest growing sectors in the crypto industry. The CCBFDEFI is ...
plusDEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
Lausanne, Switzerland and Durban, South Africa (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate ...
plus- 2
Digital Baroque: History Meets Algorithm, a future-looking exhibition that channels history, opens 31 January-7 February, 2022 on the newly launched 4ART NFT+ marketplace
plus DEBIOPHARM IINVESTS IN VERISIM LIFE’S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH
Lausanne, Switzerland - San Francisco (ots) - Funding to support BIOiSIMTM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today their co-investment in California-based start-up VeriSIM Life’s ...
plusDEBIOPHARM FURTHER EXPLORES THE POTENTIAL OF ITS POTENT, HIGHLY SELECTIVE WEE1 INHIBITOR DEBIO 0123 IN PHASE 1 CANCER STUDY
Lausanne, Switzerland (ots) - Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the first patient treated in the newly ...
plusFirmenich Demonstrates Consistent Global Environmental Leadership with fourth CDP Triple "A"
Geneva, Switzerland (ots/PRNewswire) - One of only two companies worldwide to achieve "A" in climate, water and forests for four consecutive years Firmenich, the world's largest privately-owned fragrance and taste company, has been awarded a fourth consecutive Triple "A" by CDP for the Group's leadership in transparency and action on climate change, water security and ...
plusLugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City
Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, has promoted an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. Lugano is increasingly a Blockchain & Crypto-Friendly City. After the launch at the ...
plusLugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City
Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, has promoted an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. Lugano is increasingly a Blockchain & Crypto-Friendly City. After the launch at the ...
plusLugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City.
Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, promotes an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. An unmissable opportunity to look into this new sector of digital art, discover ...
plusFDI World Dental Federation: Prescribing of dental antibiotics up 22% in England during first year of COVID-19 / Prescriptions of all other antibiotics fell during the same period
plusSwiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos
Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...
plusRoche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Basel, Switzerland (ots/PRNewswire) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with ...
plusThe International Osteoporosis Foundation (IOF)
Action for bone health is needed now more than ever, urges IOF
plusCARB-X FUNDS THE 3RD ROUND OF DEBIOPHARM’S TARGETED ANTIBIOTIC PROGRAM TO COMBAT RESISTANT N. GONORRHOEAE INFECTIONS
Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...
plusDEBIOPHARM & DEXA MEDICA LAUNCH TRIPTORELIN COLLABORATION TO BRING NEW HOPE TO WOMEN WITH ENDOMETRIOSIS
Lausanne, Switzerland – Tangerang, Indonesia (ots) - Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptorelin for the treatment of women with gynecological disorders, ...
plusSYNOVA files lawsuit against Sitec for patent infringement
plusDEBIOPHARM ENCOURAGES BREAKTHROUGH CANCER RESEARCH IN JAPAN THROUGH ITS COMPETITIVE JCA MAUVERNAY AWARD
Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research –Dr. Shumpei Ishikawa and ...
plus- 2
How we can all help improve standards of care for children with clefts to optimize their oral health / FDI World Dental Federation (FDI) releases new educational resources to mark World Smile Day®
plus - 2
World premiere: Viva Frida Kahlo – Immersive Experience
plus Child abuse in Europe: Victims' groups launch initiative to come to terms with European abuse cases
Bern, Switzerland (ots) - At an international meeting in Switzerland, victims' groups from all over Europe launched the large-scale "Justice Initiative". With this political initiative, abuse of children, especially in state and church institutions, is to be comprehensively dealt with for the first time in all European countries. A motion to bring the processing of ...
plus